Ribociclib-induced visual hallucination in a patient with metastatic breast cancer.

Author: BulutNilufer, DemirerSerhat, ErdemGokmen Umut, KapaganTanju

Paper Details 
Original Abstract of the Article :
Cyclin-dependent kinase (CDK) 4/6 inhibitors are widely used in combination with aromatase inhibitors or fulvestrant for the treatment of locally advanced or metastatic hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2-) breast cancer. Hematological toxicities (e.g. neu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/10781552231180463

データ提供:米国国立医学図書館(NLM)

A Rare Side Effect: Ribociclib-Induced Visual Hallucination

The field of [Oncology] is constantly advancing in its fight against [Cancer]. While [Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors] like [Ribociclib] have proven effective in treating [Metastatic Breast Cancer], this case report presents a rare and previously undocumented side effect: [Visual Hallucination]. This case highlights the importance of vigilant monitoring for potential adverse events, even those that are uncommon.

The Importance of Vigilance in Cancer Treatment

This case report underscores the importance of thorough monitoring for potential side effects, even those that are rare. It serves as a reminder that while [CDK 4/6 Inhibitors] are valuable tools in [Cancer Treatment], there are potential risks that must be carefully considered. The study highlights the need for open communication between patients and healthcare providers to ensure the safety and well-being of those undergoing treatment.

Navigating the Side Effects of Cancer Therapies

The side effects of [Cancer Therapies] can be a challenging aspect of treatment. This case report emphasizes the importance of careful monitoring and open communication to ensure the best possible outcomes for patients. By being aware of potential adverse events, both patients and their healthcare providers can work together to manage these challenges and optimize treatment effectiveness.

Dr.Camel's Conclusion

The fight against [Cancer] is a demanding journey, often fraught with challenges. This case report serves as a reminder that even the most promising therapies can have unexpected side effects. By remaining vigilant, fostering open communication, and prioritizing patient safety, we can navigate this complex landscape with greater knowledge and compassion.

Date :
  1. Date Completed 2023-10-23
  2. Date Revised 2023-10-23
Further Info :

Pubmed ID

37306182

DOI: Digital Object Identifier

10.1177/10781552231180463

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.